Should you buy Oura stock, the smart ring leader?

Oura, the leader in smart rings, is preparing for its IPO, one of the most anticipated tech listings of the season. The company is already profitable and growing rapidly, but it is eyeing a valuation of over $16 billion. Should you buy Oura stock at its debut, wait, or stay away? The article Should you buy Oura stock, the smart ring leader? first appeared on Cryptoast.

The wearable technology sector is set to reach a major turning point with Oura's impending initial public offering on the Nasdaq. Specializing in smart rings, the Finnish company, now anchored in the United States, has established itself as an industry benchmark thanks to a discreet device capable of capturing accurate biometric data via the finger's arteries. With approximately 5 million paying users and a commercial footprint extending across 56 markets, the company boasts a hybrid business model blending hardware sales and recurring subscriptions, with the latter accounting for a significant share of its revenue.

Financially, Oura stands out from other tech players by tapping the public market with an already profitable structure. Recent figures demonstrate impressive momentum, with revenue jumping 74% over the first nine months of 2026 to reach $1.21 billion. This solid profile, supported by sharply rising net income, is drawing strong investor interest. The company is aiming for a market capitalization exceeding $16 billion, an ambition reflecting management's confidence in its future growth prospects.

Despite these positive metrics, several gray areas call for caution. The firm's targeted valuation, equivalent to roughly 11 times its annual revenue, places high performance pressure on a market that is still maturing. Moreover, a heavy reliance on a single product exposes the company to major operational and competitive risks. The potential entry of tech giants into this specific niche could erode Oura's margins, while ongoing litigation regarding the scientific accuracy of its sleep tracking adds non-negligible legal uncertainty.

All in all, Oura's IPO offers a compelling opportunity to invest in the undisputed leader of a booming technology segment. For investors, the challenge lies in weighing the company's proven growth against the risks inherent in its concentrated business model. While exposure to the connected health sector represents an attractive strategic bet, prudence remains advisable until risks surrounding current litigation and competition from smartphone market leaders are fully cleared.